Gut Health Spotlight – Understanding Gastroenteritis and Inflammatory Bowel Diseases

 “The Crud Going Around”

Gastroenteritis, often called “the crud going around,” is a common yet disruptive ailment affecting individuals worldwide. While viral or bacterial infections frequently cause it, its implications can sometimes extend beyond the immediate discomfort. In some cases, it’s believed to contribute to the onset of more chronic conditions, including inflammatory bowel disease (IBD).

Exploring IBD: The Role of Nutrition and Innovative Approaches

Inflammatory bowel diseases such as ulcerative colitis and Crohn’s disease remain enigmas in modern medicine, with no definitive cause identified. Despite this, nutrition remains a powerful tool in managing these conditions and enhancing patient outcomes. Carrington Laboratories Inc. sponsored an open pilot clinical study with pure Aloe Acemannan multi-site study. Clinical improvements were encouraging, but a more formal study with a control population was not conducted.

One innovative, promising approach is NEW EDEN, a nutritional intervention containing Acemannan currently being studied in pilot trials. Preliminary results indicate significant benefits for individuals with IBD, including reduced inflammation and improved symptom control.

A Theory on the Origins of IBD

A leading theory about the onset of IBD involves post-gastroenteritis complications. Research suggests that viral or bacterial infections may alter the DNA of bowel cells, enabling these infectious agents to commandeer cellular processes. This theory aligns with emerging evidence that gut microbiota can influence gut health, brain function, and other organs’ activity. It is known that cells of the G.I. tract release cytokines (Cell activators) and hormones. Gastroenteritis may alter this function and lead to IRB syndromes.

This perspective underscores the interconnectedness of our organ systems: cells in one organ can communicate with and impact those in another organ or system. When this communication is disrupted, systemic deviations from normal health can arise.

Acemannan: Restoring Healthy Cellular Communication

Acemannan, a polysaccharide derived from aloe vera, has gained attention for its ability to modulate the immune system and support cellular health. Research suggests that Acemannan helps to “correct bad communication” among cells, potentially reversing the harmful effects caused by post-gastroenteritis alterations. Nine Acemannan molecules in three chains are assembled in cellular synthesis to become a cell membrane domain called homeostasis for cellular balance and harmony.

By promoting balanced cellular interaction, Acemannan could play a pivotal role in improving outcomes for individuals with IBD and other chronic conditions rooted in cellular miscommunication.

The Road Ahead

While gastroenteritis is often dismissed as a short-term inconvenience, its potential role in triggering chronic diseases like IBD highlights the importance of ongoing research and innovation. Nutritional solutions like NEW EDEN and immune modulators like Acemannan represent promising frontiers in addressing these complex conditions.

Stay tuned for further updates on groundbreaking research and practical insights into managing gut health and overall wellness supported by dietary supplementation.

Disclaimer: This newsletter is for informational purposes only and is not intended to provide medical advice. Consult a healthcare professional for personalized recommendations.

.What is a good health-supporting solution?

Milagro contains multiple so-called ”friendly” bifidobacteria that contribute to maintaining healthy gut bacteria strains.

The powder can be put in yogurt or smoothies with one’s dietary supplement.  Any acceptable beverage of food is acceptable. These health-supporting bacteria maintain the normal circadian rhythm that supports an individual’s ability to “go with the flow” of life’s stresses and avoid sleep disorders, anxiety, and other negative symptoms provoked by a modern complex environment.